Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies show it lowers kidney-related complications by 24 per cent. This offers ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

Regular consumption of garlic in cooking can contribute to long-term kidney protection. Known for supporting urinary tract health, cranberries also benefit the kidneys directly. These tart berries ...

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for kidney failure. The U.S. Food and Drug Administration (FDA) has ...

These results demonstrate that we can capture thousands of atheroembolic particles during renal stenting procedures under protection, and that increasing captured particle counts greater than 60 ...

With this approval, Ozempic becomes the most broadly indicated drug in its class, now covering diabetes control, heart disease risk reduction, and kidney protection. CKD affects about 37 million ...